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E-CIGARETTE USE AND PREGNANCY OUTCOMES 
 
Abstract: This research study investigates the incidence and outcomes of e-cigarette use in 
pregnant patients at Brody School of Medicine through a retrospective analysis of medical 
records and a prospective survey. The need for this research is evidenced by the lack of 
knowledge in this topic area as seen through the duration of a concise literature review entailing 
the history, contents, FDA concerns, addictive properties, and the comparison of cigarettes 
versus e-cigarettes. Through data analysis, plausible correlations between the usage of e-
cigarettes and pregnancy outcomes will be detailed. These findings will lead to greater awareness 
of complications due to e-cigarettes in the medical community which is especially important in 
the nicotine-dependent Eastern North Carolina area. 
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Introduction 
 Electronic cigarettes (e-cigarettes) are a form of electronic nicotine delivery systems that 
deliver nicotine in the form of aerosol (Grana, 2013).  The e-cigarette is composed of a unit that 
contains e-liquid that can be comprised of nicotine, flavor additives, or a variety of other 
compounds (Food and Drug Administration, 2017).  The worldwide use of e-cigarettes has 
steadily increased over the past decade due to rapid marketing and aggressive placement of these 
products (Yamin, 2010).  With limited regulation of manufacturing, nicotine content, and 
knowledge about health safety, there are great concerns about the potential health consequences 
and the increased prevalence of e-cigarette, especially since they have not been proven to aid in 
smoking cessation (Grana, 2013).  There is limited research about the impact these devices have 
on the health of users and the effects they have on other individuals in the users environment 
(Schripp et. Al., 2010).  In recent findings, the Center for Disease Control (CDC) has reported 
that approximately half of the calls to poison centers are due to e-cigarette misuse by individuals 
twenty years and older (Chatham-Stephens et al., 2014). The lack of research has created an aura 
of uncertainty and controversy around a popular product in the general population. This 
popularity is indicated by the findings presented by researchers at the CDC that around 12.6% of 
adults in the United States have tried an e-cigarette at least once in their lifetime (CDC, 2015). 
Of this population, 21.6% were between the ages of 18-24 years old (CDC, 2015). Additionally, 
more than one-half of this total population were current or former conventional cigarette users 
(CDC, 2015).  
 Chinese pharmacist Hon Lik originally created the e-cigarette, and now there are more 
than 2500 brands sold worldwide (Yamin 2010).  There is little or no data on efficacy of the e-
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cigarette as a smoking cessation aid (Grana, 2013).  The amount of nicotine delivered to the 
smoker varies greatly among the various brands of e-cigarettes (Cahn et al 2011).  The American 
Food and Drug Administration (FDA) has only recently begun to regulate electronic cigarettes in 
2016 under the new FDA Tobacco Rule (FDA, 2016).    
 The World Health Organization (WHO) has found that “tobacco is the single most 
preventable cause of death in the world today”.  According to the Center for Disease Control 
(CDC), tobacco use kills more than 1 million individuals in North and South America every year 
(CDC, 2013).  Specifically, in North Carolina, in 2013, 21.8% of individuals above the age of 18 
use cigarettes, and 5.8% of the same population use e-cigarettes (CDC 2013).  This ranks North 
Carolina the 29th highest state in terms of tobacco usage (CDC 2013). 
 There is a clear trend of increased use e-cigarettes in the United States but the personal 
reasons for the use of e-cigarettes vary in the general population.  A recent study completed 
through online surveys found that the most common reasons for e-cigarette use was personal 
smoking cessation and health concerns, health considerations for others exposed to second hand 
tobacco smoke, and the convenience of the product use (Huang et al 2016).  This study on e-
cigarette use, among others, generally conclude by stating that there is a need for scientific 
research to provide e-cigarette consumers with reliable and correct information regarding the 
effects that use of these devices have on consumers.  
 Since a large number of individuals in Eastern North Carolina (22%) are dependent on 
nicotine, it is important that research be done in the area to bring awareness to the issues that 
surround the lack of knowledge about the e-cigarette (CDC, 2013).  While there exists a gap in 
knowledge concerning the topic of e-cigarettes, a greater gap exists in the current understanding 
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of the effect of e-cigarette use during pregnancy.  For these reasons, it is important to delve 
deeper into the interrelations that may exist between pregnancy outcomes and e-cigarettes. 
 In the most recent report by the Surgeon General on the health consequences of smoking 
during pregnancy, over 100,000 cases of premature death in infants resulted from smoking (US 
Department of Health and Human Services, 2014).  With respect to pregnancy and birth, women 
who smoke more than four conventional cigarettes per day during pregnancy have “small for 
date babies” and often deliver their infants before term (US Department of Health and Human 
Services, 2014).  Nicotine exposure during pregnancy could lead to preterm birth, stillbirth, 
ectopic pregnancies, oral facial clefts, fetal growth restrictions, and negative effects on fetal brain 
development (US Department of Health and Human Services 2014). The safety of e-cigarettes 
has not been established for pregnant women (ACOG, 2011).  The American College of 
Obstetricians and Gynecology (ACOG) has stressed preventative interventions that could reduce 
the prevalence of smoking during pregnancy.  In fact, ACOG requires smoking cessation 
counseling for all pregnant women (ACOG, 2011).  While screening for conventional cigarettes 
in routine, obstetricians and gynecologists may not specifically screen for the usage of electronic 
cigarettes during pregnancy. A recent study surveyed more than a thousand ACOG members and 
found that only 53% of this population screened their patients for the usage of any non-
combustible tobacco products such as chewing tobacco and snuff (England, 2014).   
Since vapors from e-cigarettes do not contain the combustion tars found in cigarette 
smoke, they are assumed to be less hazardous to the health of the user (Bullen, 2010). Vapors 
from e-cigarettes do not contain carbon monoxide which is an embryo toxic component of 
cigarette smoke (Bullen, 2010). There are lower amounts of nicotine absorption from e-cigarettes 
than conventional cigarettes presumably because the tars in tobacco smoke facilitate nicotine 
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uptake (Bullen, 2010). Animal studies have shown that nicotine can damage embryo 
development by reducing uterine blood flow (Holbrook, 2016).  Large doses of nicotine are 
required to show an inhibition of fetal growth, but smoking does cause a transitory drop in blood 
flow to the placenta which could have adverse consequences during the embryonic phase of fetal 
development (Holbrook, 2016).  People who are addicted to nicotine consume increased amounts 
of nicotine to return their blood levels to their “comfort zone” level.  Nicotine-addicted cigarette 
smokers on arising raise their blood nicotine to their comfort range within five minutes of the 
onset of smoking their first morning cigarette (Holbrook, 2016).  .  This is often accompanied 
with light headiness or dizziness, which are symptoms of nicotine ganglionic blockade, and this 
level of nicotine exposure could reduce placental blood perfusion (Holbrook, 2016). In a study 
analyzing the effects of e-cigarette aerosol exposure in Xenopus laevis embryos and mammalian 
neural crest cells, it was found that e-cigarette exposure could have detrimental and adverse 
effects on craniofacial development (Kennedy et al., 2017). The potential vulnerability of the 
developing fetus to chemical insults from nicotine “over dosing” during early embryonic 
development, suggests research is needed to determine whether e-cigarettes are safe or unsafe for 
use in pregnancy.   
 This is becoming more important because of increased use of e-cigarettes in the past 
decade and the apparent lack of recording e-cigarettes use in pregnancy.  Research on the health 
consequence of e-cigarette use in needed.  This research project aims to determine the frequency 
of e-cigarette use, and the frequency that e-cigarette usage is recorded in patient records at the 
Brody School of Medicine Obstetrics and Gynecology Department’s outpatient clinics.  The low 
frequency of adverse pregnancy outcomes makes it important to document all factors that could 
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potentially contribute to an adverse outcome.  With systematic recording of environmental 
factors the likelihood of detecting factors contributing to a low frequency events is increased. 
 The variables that are utilized in this study are APGAR score at 1 minute, APGAR score 
at 5 minutes, birthweight of the newborn (BWT), and mother’s gestational age (GAGE). The 
APGAR score is a measurement that assesses the newborn’s appearance, pulse, grimace 
responses, activity, and respiration. These five factors are each assessed on a scale of 0 to 2 and 
are combined to give a total perfect score of 10. This score is taken twice, once at the first minute 
after birth to assess how the newborn did during the birthing process, and once at five minutes 
after birth to assess how the newborn is doing outside the mother’s womb. The birthweight 
(BWT) of the newborn is assessed in grams shortly after birth. The mother’s gestational age is 
the measure of time in weeks that the pregnancy lasted. Typically, a healthy pregnancy will 
result in the mother having a gestational age of approximately 40 weeks.  
Purpose of this Study 
 The purpose of this study is to examine the effect the usage of e-cigarettes on pregnancy 
outcomes. The study has two components. The first component is a prospective questionnaire to 
determine conventional and electronic cigarette use in patients at the East Carolina University 
obstetrics and gynecology clinic.  The second component is a retrospective chart review 
examining birth outcomes of patients and recording whether electronic cigarette use is 
documented in patient charts.    
Hypothesis 
It is hypothesized that the use of e-cigarettes is recorded in the medical records of patients 
receiving care at the ECU Brody OBGYN Clinics. It is also hypothesized that the usage of 
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electronic cigarettes will shorten the term length of the pregnancy and reduce the birth weight of 
the newborn when studying non-diabetic women who do not engage in illicit drugs.   
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Methodology 
 We obtained approval for this research from the UMCIRB (University Medical Center 
Institutional Review Board, a board of with members from Vidant Medical center, East Carolina 
University and the lay public).  To maintain patient confidentiality research data was stored in an 
OBGYN Departmental folder on the ECU Pirate-drive dedicated to the study.  Only study team 
members had access to the files.  Data was stripped of patient identifiers (HIPAA regulated 
information) prior to data analysis. 
Prospective Survey Method 
 The incidence of e-cigarette usage in the ECU clinic population was estimated from 
patient responses to a prospective questionnaire administered by medical staff and doctors at 
Brody School of Medicine Clinics.  Subjects were pregnant, non-diabetic women who were not 
using of illegal drugs.  The questionnaire is shown in figure 1.  The instructions allowed the 
subjects of participate on a volunteer basis in an anonymous fashion. 








1. Is this your first pregnancy? 
2. What is your age range?  
3. Have you smoked cigarettes during pregnancy?  
4. Are you currently using cigarettes while pregnant?  
5. Have you utilized electronic cigarettes while pregnant?  
6. Are you currently using electronic cigarettes while pregnant?  
7. What best describes your reasoning for using electronic cigarettes?  
8. How often do you utilize electronic cigarettes?  
9. Are you aware that there is the potential for trace amounts of nicotine to be present within electronic 
cigarettes?  
10. Knowing the effects of nicotine on an unborn baby, does the presence of nicotine in electronic 
cigarettes influence you to stop smoking electronic cigarettes or refrain from using them in the future?  
 
10 
E-CIGARETTE USE AND PREGNANCY OUTCOMES 
Retrospective Analysis Method 
 In the retrospective analysis component of this study, we retrospectively examined 
patient charts of pregnant women who were consulted with at the ECU Outpatient Clinics prior 
to their pregnancy and delivered at Vidant Medical Center.  The charts of women who delivered 
at the Vidant Medical Center between 1/15/2015 and 10/5/2016 were examined.  The data that 
was collected is indicated in figure 2 and included: infant birth weight (BWT), electronic 
cigarette usage, APGAR score at one minute (APGAR1), APGAR score at five minutes 
(APGAR5), and the gestational age of the mother (GAGE). Additionally, data was collected in 
regards to the women’s smoking status (Current Smoker, Non-smoker, and Former Smoker). 
Participants in this study were pregnant women at the Brody School of Medicine Clinic who are 
not engaged in the use of illicit drugs. 
FIG 2. RETROSPECTIVE ANALYSIS VARIABLES 
Newborn Infant Birth Weight (BWT) 
Mother’s Usage of Electronic Cigarettes (ECIGUSE) 
APGAR Score at One Minute (APGAR1) 
APGAR Score at Five Minutes (APGAR5) 
Gestational Age (GAGE) 
Mother’s Smoking Status During Pregnancy (Current, Non-, or Former Smoker)  
 
Data and Results 
Prospective Questionnaire Data and Results  
The prospective component of the study, the electronic cigarette usage questionnaire, was given 
to new patients at the ECU Women’s Physician’s clinic. A total of 218 patients were 
anonymously surveyed. The results are summarized in Figure 3.  
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Of these patients, four patients (n=4 answered the question “Do you currently use 
electronic cigarettes?” with a ‘yes’. The patients who responded with a ‘yes’ when asked about 
e-cigarette use (n=4) were 18-25 years old (n=2) and 26-32 years old (n=2). Of the patients who 
responded ‘yes’ to e-cigarette use, four patients (n=4) answered that their reasoning for utilizing 
e-cigarettes during pregnancy is because they believed it was a safer alternative compared to 
smoking traditional cigarettes. A total of 138 respondents answered the question “Are you aware 
that there is nicotine present within electronic cigarettes?” with a ‘yes’ (n=138), and 74 
respondents answered with ‘no’ (n=74). The majority of responses to this question was ‘yes’ for 
all age ranges identified in the survey. The majority of the respondents between the ages of 14-
17 years old answered the question “Knowing that there is nicotine present in electronic 
cigarettes, would you still consider using electronic cigarettes?” with a ‘yes’ (n=57) and only 
twenty responded with a ‘no’ (n=20). The majority of respondents between the ages of 18-25 
years old (n=78) responded to this question with a ‘yes’ (n=53) and fifteen responded by saying 
FIG 3. PROSPECTIVE ANALYSIS RESULTS   
What best describes your reasoning for using electronic cigarettes?  Responses  
I do not use electronic cigarettes.  214 
They are a safer alternative to smoking.  4 
Are you aware that there is the potential for trace amounts of 




Knowing the effects of nicotine on an unborn baby, does the presence 
of nicotine in electronic cigarettes influence you to stop smoking 
electronic cigarettes or refrain from using them in the future?  
Responses  
No  20 
Yes 57 
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FIG 5. Knowing the effects of 
nicotine, will you use e-cigarettes? 
Responses from Previous Cigarette 
Smokers 
‘no’ (n=15). When comparing these results to question #3 that asked respondents about previous 




Retrospective Analysis Data and Results 
A retrospective analysis of patient medical records from the Obstetrician and Gynecology 










FIG 4. Knowing the effects of 
nicotine, will you use e-cigarettes? 
Responses from Non-Smokers 
FIG. 7 RETROSPECTIVE 
RESULTS  
  
VARIABLES MEAN STANDARD DEVIATION 
Smoking Status & Birth 
Weight 
Measured in Grams  
Non-Smoker (n=166) 3283.157 661.7209 
Smoker (n=32) 3143.906 624.2237 
Smoking Status & 
Gestational Age 
Measured in Weeks  
Non-Smoker (n=166) 38.58723 2.661134 
Smoker (n=32) 38.68219 1.84769 
Smoking Status & APGAR 
@ 1 min 
Measured in Minutes   
Non-Smoker (n=166) 7.795181 1.642312 
Smoker (n=32) 7.1875 2.038935 
Smoking Status & APGAR 
@ 5 min 
Measured in Minutes  
Non-Smoker (n=166) 8.626506 0.9106886 
Smoker (n=32) 8.5625 0.7593503 
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medical records.  Of these medical records, pregnancies that resulted in still born babies were 
removed and resulted in a total of 198 medical records that were utilized in this study. None of 
the records examined included notes of electronic cigarette usage during pregnancy.  However, 
other variables such as birth weight, smoking status, gestational age, and APGAR scores 
displayed trends. The results are summarized in Figure 7.  
 According to the results, the average birthweight for a newborn who was born to a 
mother who does not smoke (nonsmoker, n=166) was between the range of 1500 grams and 
4600 grams with a mean birthweight of 3283 grams.  For mothers who did smoke (smoker, 
n=32), the birthweight for the newborn was between the range of 2000 and 4500 grams with a 
mean birthweight of 3143 grams.  
Another variable that was assessed in the retrospective analysis was the mother’s 
gestational age at delivery (GAGE). According to figures 6 and 7, the mean GAGE for 
nonsmokers is 38.58 weeks. The mean GAGE for smokers is 38.68 weeks. The mean APGAR1 
score for newborns born to non-smokers was 8, and the mean APGAR1 score for newborns born 
to smokers was 8 as well. The mean APGAR5 score for newborns born to nonsmokers was 
8.626, whereas the mean APGAR5 score for newborns born to smokers was 8.5625. 
 Of these findings, the trends between current smoking status compared to APGAR 1, 
AGAR 5, and birthweight of the newborn are significant.  
The results from the 1-tail and 2-tail tests of variables in the retrospective analysis as they 
compare the smoking status are indicated in Figure 8.  
FIG 8. Results from 1 and 2 Tail Test as compared to Smoking Status 
VARIABLE P-Value for 2-Tail Test P-Value for 1-Tail Test 
Birth Weight 0.16 0.004 
Gestational Age at Delivery 0.07 0.018 
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APGAR score at 1 minute 0.17 0.003 
APGAR score at 5 minutes 0.058 0.09 
 
Of these values, the 1-tail tests indicate significance for the following variables when 
compared to smoking status: birth weight, gestational age, and APGAR score at 1 minute. 
Figures 12-14 illustrate the differences between smokers and nonsmokers when assessing birth 
















Fig 9. Gestational Age Distribution 
in Non-Smoker Population (n=166) 
Fig 10. Gestational Age Distribution 

















Fig 11. Birth Weight Distribution 
in Non-Smoker Population (n=166) 
Fig 12. Birth Weight Distribution 
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According to figure 9, 3.6% of the non-smoker population delivered newborns before 30 
weeks. In comparison, figure 10 indicates that 12.5% of the smoker population delivered 
newborns before 30 weeks. Figure 11 indicates that 9% of the non-smoker population delivered 
newborns that had a birth weight below 2400 grams. In comparison, figure 12 indicates that 
15.6% of the smoker population delivered newborns that had a birth weight below 2400 grams.  
Discussion 
The hypothesis that was established prior to the study was that e-cigarette usage would be 
recorded in the medical records of patients receiving care at the ECU Brody OB/GYN Clinics. 
Additionally, it was hypothesized that e-cigarette usage would negatively impact birth outcomes 
including gestational age, APGAR score at 1 and 5 minutes, and birthweight. The results indicate 
that e-cigarette usage is not recorded in the medical records of patients receiving care at the ECU 
Brody OB/GYN Clinics and in the Vidant Medical Center medical records.  No e-cigarette users 
were identified in the retrospective analysis portion of this study between 1/15/2015 and 
10/5/2016.  However, conventional smoking status was noted in the medical records of patients 
receiving care at the ECU Brody OB/GYN Clinics. For this reason, the study was shifted 
towards looking at the birth outcomes as it relates to conventional cigarette smoking status. The 
variables that were assessed and identified from the medical records in the retrospective analysis 
were: APGAR score at 1 minute, APGAR score at 5 minute, gestational age, newborn 
birthweight, and mother’s smoking status. Of these variables, the data suggests that current 
conventional cigarette smoking status has an effect on APGAR score at 1 minute, gestational 
age, and birthweight.   
It is important to note that from the total population that was utilized in the retrospective 
portion of this study (n=198), a total of 166 patients were non-smokers (n=166) and only 32 were 
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smokers (n=32). This means that there was 5x as many pregnant women who were identified as 
non-smokers used in this study as compared to smokers. The results would lead to greater 
significance if the population of smokers and non-smokers were more even in number. 
Typically, in studies within the field of Obstetrics and Gynecology, outcomes such as gestational 
age, birthweight, and APGAR score are not evenly distributed.  
The results from the prospective study indicated that, while no e-cigarettes users were 
found in the retrospective analysis of the medical records, four survey participants answered with 
a ‘yes’ to e-cigarette use. This means that medical professionals should be more cognizant of 
inquiring about e-cigarette use by their patients whether or not it is a question that the medical 
record system asks for. Additionally, the data suggests that of the pregnant patients that were 
surveyed, e-cigarette use was more common in younger patients. The most common reason for 
utilizing e-cigarettes was due to respondents seeing it is a ‘safer’ alternative to smoking 
conventional cigarettes. The data implies that most patients surveyed do not realize that trace 
amounts of nicotine are present within e-cigarettes, but after completing the survey they would 
not be likely to engage in e-cigarette use.  
This research study makes evident the need for further study and investigation in the links 
between e-cigarette use and pregnancy outcomes. It is important that medical professionals not 
only inquire about e-cigarette use in their patients, but also make patients aware of the potential 
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